Clinical Research Directory
Browse clinical research sites, groups, and studies.
Gastrointestinal Dysmotility on Aspiration Risk
Sponsor: Boston Children's Hospital
Summary
The hypothesis of this study is that esophageal and gastric dysmotility increase the risk of developing aspiration-associated symptoms in children with neurologic impairment. The investigators are conducting a ten week cross over study comparing prucalopride to famotidine for the treatment of aspiration-associated symptoms.
Official title: The Impact of Upper Gastrointestinal Dysmotility on Aspiration-associated Symptoms
Key Details
Gender
All
Age Range
5 Years - 21 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2025-02-13
Completion Date
2027-05-31
Last Updated
2025-12-26
Healthy Volunteers
No
Conditions
Interventions
Prucalopride
Prucalopride 0.04 mg/kg/day
Famotidine
Famotidine 0.4 mg/kg/day
Locations (1)
Boston Children's Hospital
Boston, Massachusetts, United States